Improving the lives of people with sickle cell disease
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Improving the lives of people with sickle cell disease

Filetype[PDF-2.68 MB]


  • English

  • Details:

    • Description:
      Tuesday, November 15, 2016, at 1 pm EST

      Sickle cell disease (SCD) describes a group of inherited disorders that can cause red blood cells to develop in an abnormal rigid sickle or crescent shape. These inflexible sickle-shaped cells can stick to the walls of blood vessels and block the flow of blood completely, leading to a lack of oxygen in surrounding tissues. In addition to sudden, excruciating pain events known as pain crises, SCD can lead to strokes, organ damage, joint and bone problems, and other severe health consequences. The effects of SCD begin around 5 or 6 months of age and continue over a person's lifetime. There is no national registry for SCD, but experts estimate that this disease affects approximately 100,000 people in the United States alone.

      Over the past 30 years, treatments for SCD and its complications have improved average life expectancy, but these treatments can be costly and invasive. Additionally, healthcare needs and access to care may change over the course of a patient's life. Through continued collaboration with clinicians, researchers and the SCD community, we can identify critical gaps and better understand how these treatments can improve the lives of people with SCD.

      This session of Public Health Grand Rounds discusses SCD, what we know, and how far we have come in just a few decades.

      Presented by: Mary Hulihan, DrPH, Health Scientist, Epidemiology and Surveillance Branch, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC ["Using Data to Understand Gaps in Care and Outcomes"]; Kim Smith-Whitley, MD, Medical Director, Sickle Cell Clinical Program, Children's Hospital of Philadelphia; Chief Medical Officer (Immediate Past), Sickle Cell Association of America ["The Sickle Cell Community and Pediatric Care"];

      Kathryn Hassell, MD, Professor of Medicine, Division of Hematology, University of Colorado Denver ["Improving Outcomes for Adults with Sickle Cell Disease"]; Jean Raphael, MD, MPH, Associate Professor, Pediatrics, Baylor College of Medicine, Director, Center for Child Health Policy and Advocacy, Texas Children's Hospital ["A Health Policy Approach to Sickle Cell Disease"].

      Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds.

    • Document Type:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov